Coloplast A/S CLPBF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 6.14% | 11.27% | 9.33% | 6.41% | 6.54% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 6.14% | 11.27% | 9.33% | 6.41% | 6.54% |
| Cost of Revenue | 9.06% | 17.01% | 10.60% | 1.02% | 6.18% |
| Gross Profit | 4.75% | 8.60% | 8.72% | 9.10% | 6.71% |
| SG&A Expenses | 6.06% | 10.51% | 9.94% | 8.20% | 6.54% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 7.02% | 10.59% | -30.87% | -572.47% | -118.95% |
| Total Operating Expenses | 8.04% | 13.71% | 10.77% | 3.46% | 6.01% |
| Operating Income | 1.15% | 4.77% | 5.47% | 14.68% | 7.96% |
| Income Before Tax | 40.22% | -190.82% | 10.42% | 3.12% | -13.26% |
| Income Tax Expenses | -22.96% | -151.32% | -40.73% | 150.13% | 58.58% |
| Earnings from Continuing Operations | 82.37% | -215.89% | 45.94% | -29.21% | -33.39% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 82.37% | -215.89% | 45.94% | -29.21% | -33.39% |
| EBIT | 1.15% | 4.77% | 5.47% | 14.68% | 7.96% |
| EBITDA | 135.34% | 5.64% | 6.82% | 14.13% | 8.30% |
| EPS Basic | 82.51% | -216.00% | 45.95% | -29.34% | -33.56% |
| Normalized Basic EPS | 33.44% | 23.19% | 8.24% | 27.01% | -10.12% |
| EPS Diluted | 82.56% | -216.00% | 46.05% | -29.32% | -33.51% |
| Normalized Diluted EPS | 33.44% | 23.19% | 8.24% | 27.01% | -10.02% |
| Average Basic Shares Outstanding | -0.09% | -0.09% | 0.00% | 0.18% | 0.27% |
| Average Diluted Shares Outstanding | -0.09% | -0.09% | 0.00% | 0.18% | 0.14% |
| Dividend Per Share | -- | 8.85% | -- | 12.55% | -- |
| Payout Ratio | -0.45% | -- | -0.21% | -- | 0.59% |